Stay updated on Pembrolizumab in Gastric Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Gastric Cancer Clinical Trial page.

Latest updates to the Pembrolizumab in Gastric Cancer Clinical Trial page
- Check4 days agoChange DetectedThe page revision was updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check32 days agoChange DetectedAdded a link to the Genetic and Rare Diseases Information Center as a resource and included the 'Gastric cancer' term; removed the funding-status notice and an older revision note.SummaryDifference0.5%

- Check39 days agoChange DetectedAdded a site-wide notice about government funding and NIH operations. Updated page revision from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check46 days agoChange DetectedAdded a Show glossary UI element and displayed a new 'Last Update Submitted that Met QC Criteria' field. Updated the footer to 'No FEAR Act Data' (case change) and bumped the page version from v3.3.4 to v3.4.0.SummaryDifference0.2%

- Check61 days agoChange DetectedThe page displays an updated revision label, changing from v3.3.3 to v3.3.4 with no changes to the study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check82 days agoChange DetectedAdded a consolidated Locations section listing sites in Japan (Chiba, Ehime, Gunma, Hokkaido, Hyōgo, Ibaraki, Kanagawa, Miyagi, Osaka, Saitama, Shizuoka, Tochigi) and removed the previous per-location blocks.SummaryDifference1%

Stay in the know with updates to Pembrolizumab in Gastric Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Gastric Cancer Clinical Trial page.